STOCK TITAN

CXApp SEC Filings

CXAI NASDAQ

Welcome to our dedicated page for CXApp SEC filings (Ticker: CXAI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

This page provides access to CXApp Inc. (NASDAQ: CXAI) SEC filings, offering a regulatory view of the company’s AI-powered workplace experience and spatial intelligence business. CXAI’s filings with the U.S. Securities and Exchange Commission include current reports on Form 8-K, annual reports on Form 10-K, quarterly reports on Form 10-Q, and other disclosures that document material events, financial performance, and capital structure.

Recent Form 8-K filings describe financing arrangements such as pre-paid purchase agreements with institutional investors and the related issuance of common stock under exemptions from registration. These documents also confirm that CXAI’s common stock and warrants, trading under the symbols CXAI and CXAIW, are registered under Section 12(b) of the Exchange Act and listed on The Nasdaq Stock Market LLC. Investors can use these filings to understand how CXAI funds its operations, manages obligations, and reports significant corporate developments.

For a broader perspective, CXAI’s periodic reports typically outline its SaaS business model, the importance of recurring subscription revenue, and the role of Agentic AI and spatial intelligence in its workplace platform. They may also discuss risk factors, customer concentration, intellectual property, and other elements relevant to an enterprise software and data processing company.

On Stock Titan, SEC documents are paired with AI-powered summaries that highlight key points, explain complex sections in plain language, and help readers quickly identify items such as revenue mix, capital transactions, and material agreements. Real-time updates from EDGAR ensure that new 10-K, 10-Q, 8-K, and Form 4 insider transaction filings appear promptly, while AI-generated insights make it easier to interpret how each filing fits into CXAI’s overall corporate and financial profile.

Rhea-AI Summary

CXApp Inc. reported that it issued an aggregate of 7,304,178 shares of common stock to Avondale Capital, LLC in a private transaction. The shares were delivered under Pre-Paid Purchase #2 and #3, which were entered into pursuant to a Securities Purchase Agreement dated March 26, 2025.

The common shares were issued on April 13, 2026, April 16, 2026 and April 17, 2026 at prices of $0.154427, $0.144872 and $0.144872 per share, respectively. The transaction was structured as an unregistered sale relying on Section 4(a)(2) of the Securities Act of 1933 for non-public offerings, and was accompanied by standard forward-looking statement cautions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

CXApp Inc. reported that Chief Executive Officer Sheikh Khurram P received new stock option awards as part of his annual compensation. On April 13, 2026, he was granted 675,000 stock options for Class A Common Stock at an exercise price of $0.16 per share, expiring on April 13, 2036. These options vest one-third on the first anniversary of the grant date, with the remaining two-thirds vesting in equal monthly installments over the following 24 months.

On the same date, he was also granted 225,000 performance-based stock options for Class A Common Stock at the same $0.16 exercise price and April 13, 2036 expiration. These performance-based options will vest based on the company’s stock price performance, tying a portion of his compensation to future market outcomes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

CXApp Inc. Chief Financial Officer Joy Mbanugo received two stock option awards as part of her annual compensation. On April 13, 2026, she was granted 187,500 stock options for Class A Common Stock with a $0.16 exercise price, vesting one-third on the first anniversary and the remainder in equal monthly installments over the next 24 months. She was also granted 62,500 performance-based stock options at the same $0.16 exercise price, which will vest based on the company’s stock price performance. These are compensation-related awards, not open-market share purchases or sales.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

CXApp Inc. reported an unregistered sale of equity securities. The company issued an aggregate of 4,116,659 shares of common stock to Avondale Capital, LLC under two Pre-Paid Purchase agreements entered into pursuant to a Securities Purchase Agreement dated March 26, 2025.

The shares were issued on March 30, 2026, April 1, 2026, April 8, 2026 and April 10, 2026 at per-share prices of $0.180453, $0.18045, $0.154427 and $0.154427, respectively. The transaction relied on the Section 4(a)(2) exemption from registration for offerings not involving a public offering.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

CXApp Inc. provides an AI-powered, mobile-first employee experience SaaS platform that helps enterprises manage hybrid workplaces, space utilization and engagement, backed by 37 filed patents, including 17 granted. Customers are largely Fortune 1000 firms across technology, financial services, manufacturing, entertainment and life sciences.

The company remains unprofitable, with net losses of $13.5 million in 2025 and $19.4 million in 2024, and a workforce of about 35 employees as of March 24, 2026. It recorded a $2.1 million goodwill impairment in 2025 and depends heavily on a few large customers; the top three represented about 40% of 2025 revenue.

CXApp previously reported material weaknesses in internal control but states these were remediated by December 31, 2025. Its stock faces Nasdaq minimum bid price noncompliance, with an extension to September 7, 2026 to regain a bid of at least $1.00 for 10 consecutive business days, or risk delisting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.75%
Tags
annual report
-
Rhea-AI Summary

CXApp Inc. reported issuing 10,028,891 shares of common stock to Avondale Capital, LLC in a private transaction under prior pre-paid purchase arrangements tied to a 2025 securities purchase agreement. The shares were delivered on multiple dates in February and March 2026 at prices between $0.156793 and $0.199381 per share, relying on an exemption from Securities Act registration for transactions not involving a public offering.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Filing
Rhea-AI Summary

CXApp Inc. disclosed that Nasdaq has granted it an additional 180-day grace period, until September 7, 2026, to regain compliance with Nasdaq’s minimum bid price rule. The company’s stock had traded below the required $1.00 per share for at least 30 consecutive business days, triggering the deficiency notice.

The extension allows CXApp’s common stock to continue trading on the Nasdaq Capital Market while it works to cure the issue. The company has informed Nasdaq it intends to address the deficiency, potentially through a reverse stock split if needed. If the closing bid is at or above $1.00 for at least ten consecutive trading days before the deadline, compliance will be restored. Failure to do so could lead to delisting, although CXApp would have the right to appeal.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.76%
Tags
current report
-
Rhea-AI Summary

CXApp Inc. files a prospectus supplement registering the resale of up to 10,026,776 shares of common stock. The supplement also covers resale of up to 10,280,000 private placement warrants, 24,080,000 shares of common stock underlying warrants, and specified resale rights of Streeterville Capital under existing agreements.

The supplement incorporates a Form 8-K reporting that Nasdaq granted an additional compliance period through September 7, 2026 to meet the $1.00 minimum bid price requirement; the company reported closing prices of $0.21 per share and $0.066 per warrant on March 11, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.76%
Tags
prospectus
-
Rhea-AI Summary

CXApp Inc. reported that it issued 4,616,481 shares of its common stock to Avondale Capital, LLC in a private transaction. The shares were delivered under a Pre-Paid Purchase #1 dated March 26, 2025, entered into pursuant to a Securities Purchase Agreement between the two parties.

The common shares were issued on January 26, 2026, January 27, 2026 and January 28, 2026 at a price of $0.24024 per share. CXApp relied on Section 4(a)(2) of the Securities Act of 1933, using an exemption for transactions not involving a public offering, which means these shares were sold without SEC registration and increase the company’s outstanding share count.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

CXApp Inc. filed a prospectus supplement covering the resale of up to 10,026,776 shares of common stock, 10,280,000 warrants, and 24,080,000 shares of common stock underlying those warrants by selling securityholders. The supplement incorporates a Current Report on Form 8-K.

The attached Form 8-K discloses that CXApp issued 4,616,481 shares of common stock to Avondale Capital, LLC under a pre-paid purchase agreement at $0.24024 per share, with issuances on January 26, 27 and 28, 2026, relying on the private offering exemption in Section 4(a)(2) of the Securities Act. CXApp’s common stock and warrants trade on Nasdaq under the symbols CXAI and CXAIW, with recent closing prices of $0.305 per share and $0.0327 per warrant, respectively.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus

FAQ

How many CXApp (CXAI) SEC filings are available on StockTitan?

StockTitan tracks 17 SEC filings for CXApp (CXAI), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for CXApp (CXAI)?

The most recent SEC filing for CXApp (CXAI) was filed on April 17, 2026.